FEATURES OF THE COURSE OF ANDROGENETIC ALOPECIA IN WOMEN WITH METABOLIC ABNORMALITIES

Download full text PDF
Issue: 
11
Year: 
2016

N. Levina Danaya Medical Cosmetic Center

Clinical and laboratory studies in women with androgenetic alopecia have made it possible to establish the features of its clinical course and characteristic hormonal and metabolic abnormalities in these patients, which necessitate the extension of their therapeutic measures.
Keywords: 
dermatology
androgenetic alopecia
women
insulin resistance
dyslipidemia
clinical characteristics

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Adaskevich V.P., Mjadelets O.D., Tihonovskaja I.V. Alopetsija / N. Novgorod: NGMA, 2000; 158.
  2. Olsen E. Female pattern hair loss // J. Am. Acad. Dermatol. – 2001; 45: 570–80.
  3. Tosti A., Piraccini B. Androgenetic alopecia. In: Tosti A, Piraccini BM, editors. Diagnosis and treatment of hair disorders: An evidence based atlas / London: Taylor and Francis, 2006; 45–56.
  4. Tosti A., Pazzaglia M., Soli M. et al. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia // Arch. Dermatol. – 2004; 140: 857–8.
  5. Kim B., Kim J., Eun H. et al. Androgenetic alopecia in adolescents: a report of 43 cases // J. Dermatol. – 2006; 33: 696–9.
  6. Tobin D., Gunin A., Magerl M. et al. Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: Implications for hair growth control // J. Invest. Dermatol. – 2003; 120: 895–904.
  7. Randall V. The role of 5a-reductase in health and disease //Baillieres Clinical Endocrinology and Metabolism. Eds M. Sheppard, P. Steward. Vol. 8 Hormones, Enzymes and Receptors / London: Tindall, 1994; 405–31.
  8. Kaufman K. Androgens and alopecia // Mol. Cell. Endocrinol. – 2002; 198: 89–95.
  9. Sawaya M., Price V. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia // J. Invest. Dermatol. – 1997; 109: 296–300.
  10. Cousen P., Messenger A. Female pattern hair loss in complete androgen in sensitivity syndrome // Br. J. Dermatol. – 2010; 162: 1135–7.
  11. Cotton S., Nixon J., Carpenter R. et al. Factors discriminating men with coronary heart disease from healthy controls // Br. Heart J. – 1972; 34: 458–64.
  12. Massaki A., Fabi S., Fitzpatrick R. Repigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprost // Dermatol. Surg. – 2012; 38 (7 Pt. 1): 995–1001.
  13. Arias-Santiago S., Gutiérrez-Salmerón M., Castellote-Caballero L. et al. Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study // J. Am. Acad. Dermatol. – 2010; 63: 420–9.
  14. Hirsso P., Laakso M., Matilainen V. et al. Association of insulin resistance-linked diseases and hair loss in elderly men. Finnish population-based study // Cent Eur. J. Public Health. – 2006; 14: 78–81.
  15. Acibucu F., Kayatas M., Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia // Singapore Med. J. – 2010; 51 (12): 931–6.